Opexa Therapeutics Completes Patient Enrollment in Phase IIb Trial ...
PipelineReview.com (press release) - Barcelona,Spain
The trial design is a US multicenter, randomized, double-blind, placebo-controlled study of subcutaneous Tovaxin(TM) in subjects with Clinically Isolated ...
See all stories on this topic